146 related articles for article (PubMed ID: 24867525)
1. RNA-Seq profiling reveals aberrant RNA splicing in patient with adult acute myeloid leukemia during treatment.
Li XY; Yao X; Li SN; Suo AL; Ruan ZP; Liang X; Kong Y; Zhang WG; Yao Y
Eur Rev Med Pharmacol Sci; 2014; 18(9):1426-33. PubMed ID: 24867525
[TBL] [Abstract][Full Text] [Related]
2. RNA-Seq analysis identifies aberrant RNA splicing of TRIP12 in acute myeloid leukemia patients at remission.
Gao P; Jin Z; Cheng Y; Cao X
Tumour Biol; 2014 Oct; 35(10):9585-90. PubMed ID: 24961348
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR.
Handschuh L; Kaźmierczak M; Milewski MC; Góralski M; Łuczak M; Wojtaszewska M; Uszczyńska-Ratajczak B; Lewandowski K; Komarnicki M; Figlerowicz M
Int J Oncol; 2018 Mar; 52(3):656-678. PubMed ID: 29286103
[TBL] [Abstract][Full Text] [Related]
4. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
[TBL] [Abstract][Full Text] [Related]
5. NPM1 alternative transcripts are upregulated in acute myeloid and lymphoblastic leukemia and their expression level affects patient outcome.
Handschuh L; Wojciechowski P; Kazmierczak M; Marcinkowska-Swojak M; Luczak M; Lewandowski K; Komarnicki M; Blazewicz J; Figlerowicz M; Kozlowski P
J Transl Med; 2018 Aug; 16(1):232. PubMed ID: 30126426
[TBL] [Abstract][Full Text] [Related]
6. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.
Thol F; Damm F; Lüdeking A; Winschel C; Wagner K; Morgan M; Yun H; Göhring G; Schlegelberger B; Hoelzer D; Lübbert M; Kanz L; Fiedler W; Kirchner H; Heil G; Krauter J; Ganser A; Heuser M
J Clin Oncol; 2011 Jul; 29(21):2889-96. PubMed ID: 21670448
[TBL] [Abstract][Full Text] [Related]
7. A genome-wide aberrant RNA splicing in patients with acute myeloid leukemia identifies novel potential disease markers and therapeutic targets.
Adamia S; Haibe-Kains B; Pilarski PM; Bar-Natan M; Pevzner S; Avet-Loiseau H; Lode L; Verselis S; Fox EA; Burke J; Galinsky I; Dagogo-Jack I; Wadleigh M; Steensma DP; Motyckova G; Deangelo DJ; Quackenbush J; Stone R; Griffin JD
Clin Cancer Res; 2014 Mar; 20(5):1135-45. PubMed ID: 24284058
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review.
Baldus CD; Mrózek K; Marcucci G; Bloomfield CD
Br J Haematol; 2007 Jun; 137(5):387-400. PubMed ID: 17488484
[TBL] [Abstract][Full Text] [Related]
9. Elevated FOSB-expression; a potential marker of valproate sensitivity in AML.
Khanim FL; Bradbury CA; Arrazi J; Hayden RE; Rye A; Basu S; MacWhannell A; Sawers A; Griffiths M; Cook M; Freeman S; Nightingale KP; Grimwade D; Falciani F; Turner BM; Bunce CM; Craddock C
Br J Haematol; 2009 Feb; 144(3):332-41. PubMed ID: 19036090
[TBL] [Abstract][Full Text] [Related]
10. BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML).
Santamaría C; Chillón MC; García-Sanz R; Pérez C; Caballero MD; Mateos MV; Ramos F; de Coca AG; Alonso JM; Giraldo P; Bernal T; Queizán JA; Rodríguez JN; Puig N; Balanzategui A; Sarasquete ME; Alcoceba M; Díaz-Mediavilla J; San Miguel J; González M
Ann Hematol; 2010 May; 89(5):453-8. PubMed ID: 19943049
[TBL] [Abstract][Full Text] [Related]
11. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
Schlenk RF; Döhner K; Krauter J; Fröhling S; Corbacioglu A; Bullinger L; Habdank M; Späth D; Morgan M; Benner A; Schlegelberger B; Heil G; Ganser A; Döhner H;
N Engl J Med; 2008 May; 358(18):1909-18. PubMed ID: 18450602
[TBL] [Abstract][Full Text] [Related]
12. Transcriptome Profiling of Pediatric Core Binding Factor AML.
Hsu CH; Nguyen C; Yan C; Ries RE; Chen QR; Hu Y; Ostronoff F; Stirewalt DL; Komatsoulis G; Levy S; Meerzaman D; Meshinchi S
PLoS One; 2015; 10(9):e0138782. PubMed ID: 26397705
[TBL] [Abstract][Full Text] [Related]
13. Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens.
Liao W; Jordaan G; Nham P; Phan RT; Pelegrini M; Sharma S
BMC Cancer; 2015 Oct; 15():714. PubMed ID: 26474785
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukemia with myelodysplasia-related changes are characterized by a specific molecular pattern with high frequency of ASXL1 mutations.
Devillier R; Gelsi-Boyer V; Brecqueville M; Carbuccia N; Murati A; Vey N; Birnbaum D; Mozziconacci MJ
Am J Hematol; 2012 Jul; 87(7):659-62. PubMed ID: 22535592
[TBL] [Abstract][Full Text] [Related]
15. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
Lo Coco F; Pisegna S; Diverio D
Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
[TBL] [Abstract][Full Text] [Related]
16. Disease-stabilizing treatment based on all-trans retinoic acid and valproic acid in acute myeloid leukemia - identification of responders by gene expression profiling of pretreatment leukemic cells.
Reikvam H; Hovland R; Forthun RB; Erdal S; Gjertsen BT; Fredly H; Bruserud Ø
BMC Cancer; 2017 Sep; 17(1):630. PubMed ID: 28877686
[TBL] [Abstract][Full Text] [Related]
17. Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia.
Deneberg S; Grövdal M; Karimi M; Jansson M; Nahi H; Corbacioglu A; Gaidzik V; Döhner K; Paul C; Ekström TJ; Hellström-Lindberg E; Lehmann S
Leukemia; 2010 May; 24(5):932-41. PubMed ID: 20237504
[TBL] [Abstract][Full Text] [Related]
18. Identification of survival-related alternative splicing signatures in acute myeloid leukemia.
Zhang B; Yang L; Wang X; Fu D
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212178
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression of splicing factors in newly diagnosed acute myeloid leukemia.
Liu J; Huang B; Xiao Y; Xiong HM; Li J; Feng DQ; Chen XM; Zhang HB; Wang XZ
Onkologie; 2012; 35(6):335-40. PubMed ID: 22722453
[TBL] [Abstract][Full Text] [Related]
20. Characterization of kinase gene expression and splicing profile in prostate cancer with RNA-Seq data.
Feng H; Li T; Zhang X
BMC Genomics; 2018 Aug; 19(Suppl 6):564. PubMed ID: 30367578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
